Synthesis, structure and antileishmanial evaluation of endoperoxide–pyrazole hybrids

Detalhes bibliográficos
Autor(a) principal: Amado, Patrícia S. M.
Data de Publicação: 2022
Outros Autores: Costa, Inês C. C., Paixão, José A., Mendes, Ricardo F., Cortes, Sofia, Cristiano, Maria L.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.1/18238
Resumo: Leishmaniases are among the most impacting neglected tropical diseases. In attempts to repurpose antimalarial drugs or candidates, it was found that selected 1,2,4-trioxanes, 1,2,4,5-tetraoxanes, and pyrazole-containing chemotypes demonstrated activity against <i>Leishmania</i> parasites. This study reports the synthesis and structure of trioxolane–pyrazole (<b>OZ1</b>, <b>OZ2</b>) and tetraoxane–pyrazole (<b>T1</b>, <b>T2</b>) hybrids obtained from the reaction of 3(5)-aminopyrazole with endoperoxide-containing building blocks. Interestingly, only the endocyclic amine of 3(5)-aminopyrazole was found to act as nucleophile for amide coupling. However, the fate of the reaction was influenced by prototropic tautomerism of the pyrazole heterocycle, yielding 3- and 5-aminopyrazole containing hybrids which were characterized by different techniques, including X-ray crystallography. The compounds were evaluated for <i>in vitro</i> antileishmanial activity against promastigotes of <i>L. tropica</i> and <i>L. infantum</i>, and for cytotoxicity against THP-1 cells. Selected compounds were also evaluated against intramacrophage amastigote forms of <i>L. infantum.</i> Trioxolane–pyrazole hybrids <b>OZ1</b> and <b>OZ2</b> exhibited some activity against <i>Leishmania</i> promastigotes, while tetraoxane–pyrazole hybrids proved inactive, most likely due to solubility issues. Eight salt forms, specifically tosylate, mesylate, and hydrochloride salts, were then prepared to improve the solubility of the corresponding peroxide hybrids and were uniformly tested. Biological evaluations in promastigotes showed that the compound <b>OZ1</b><b>•HCl</b> was the most active against both strains of <i>Leishmania</i>. Such finding was corroborated by the results obtained in assessments of the <i>L. infantum</i> amastigote susceptibility. It is noteworthy that the salt forms of the endoperoxide–pyrazole hybrids displayed a broader spectrum of action, showing activity in both strains of <i>Leishmania</i>. Our preliminary biological findings encourage further optimization of peroxide–pyrazole hybrids to identify a promising antileishmanial lead.
id RCAP_f13aaeda9a14338f74a7e9125b1e3c13
oai_identifier_str oai:sapientia.ualg.pt:10400.1/18238
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Synthesis, structure and antileishmanial evaluation of endoperoxide–pyrazole hybridsAntileishmanial chemotherapy1,2,4-trioxanes1,2,4,5-tetraoxanesPyrazolesEndoperoxide– pyrazole hybridsPrototropic tautomerismLeishmaniases are among the most impacting neglected tropical diseases. In attempts to repurpose antimalarial drugs or candidates, it was found that selected 1,2,4-trioxanes, 1,2,4,5-tetraoxanes, and pyrazole-containing chemotypes demonstrated activity against <i>Leishmania</i> parasites. This study reports the synthesis and structure of trioxolane–pyrazole (<b>OZ1</b>, <b>OZ2</b>) and tetraoxane–pyrazole (<b>T1</b>, <b>T2</b>) hybrids obtained from the reaction of 3(5)-aminopyrazole with endoperoxide-containing building blocks. Interestingly, only the endocyclic amine of 3(5)-aminopyrazole was found to act as nucleophile for amide coupling. However, the fate of the reaction was influenced by prototropic tautomerism of the pyrazole heterocycle, yielding 3- and 5-aminopyrazole containing hybrids which were characterized by different techniques, including X-ray crystallography. The compounds were evaluated for <i>in vitro</i> antileishmanial activity against promastigotes of <i>L. tropica</i> and <i>L. infantum</i>, and for cytotoxicity against THP-1 cells. Selected compounds were also evaluated against intramacrophage amastigote forms of <i>L. infantum.</i> Trioxolane–pyrazole hybrids <b>OZ1</b> and <b>OZ2</b> exhibited some activity against <i>Leishmania</i> promastigotes, while tetraoxane–pyrazole hybrids proved inactive, most likely due to solubility issues. Eight salt forms, specifically tosylate, mesylate, and hydrochloride salts, were then prepared to improve the solubility of the corresponding peroxide hybrids and were uniformly tested. Biological evaluations in promastigotes showed that the compound <b>OZ1</b><b>•HCl</b> was the most active against both strains of <i>Leishmania</i>. Such finding was corroborated by the results obtained in assessments of the <i>L. infantum</i> amastigote susceptibility. It is noteworthy that the salt forms of the endoperoxide–pyrazole hybrids displayed a broader spectrum of action, showing activity in both strains of <i>Leishmania</i>. Our preliminary biological findings encourage further optimization of peroxide–pyrazole hybrids to identify a promising antileishmanial lead.ALG-01-0145-FEDER-022121; SFRH/BD/08242/2020MDPISapientiaAmado, Patrícia S. M.Costa, Inês C. C.Paixão, José A.Mendes, Ricardo F.Cortes, SofiaCristiano, Maria L.2022-09-09T10:06:12Z2022-08-242022-09-08T13:24:05Z2022-08-24T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.1/18238engMolecules 27 (17): 5401 (2022)1420-304910.3390/molecules27175401info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-13T02:07:57Zoai:sapientia.ualg.pt:10400.1/18238Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:08:00.606094Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Synthesis, structure and antileishmanial evaluation of endoperoxide–pyrazole hybrids
title Synthesis, structure and antileishmanial evaluation of endoperoxide–pyrazole hybrids
spellingShingle Synthesis, structure and antileishmanial evaluation of endoperoxide–pyrazole hybrids
Amado, Patrícia S. M.
Antileishmanial chemotherapy
1,2,4-trioxanes
1,2,4,5-tetraoxanes
Pyrazoles
Endoperoxide– pyrazole hybrids
Prototropic tautomerism
title_short Synthesis, structure and antileishmanial evaluation of endoperoxide–pyrazole hybrids
title_full Synthesis, structure and antileishmanial evaluation of endoperoxide–pyrazole hybrids
title_fullStr Synthesis, structure and antileishmanial evaluation of endoperoxide–pyrazole hybrids
title_full_unstemmed Synthesis, structure and antileishmanial evaluation of endoperoxide–pyrazole hybrids
title_sort Synthesis, structure and antileishmanial evaluation of endoperoxide–pyrazole hybrids
author Amado, Patrícia S. M.
author_facet Amado, Patrícia S. M.
Costa, Inês C. C.
Paixão, José A.
Mendes, Ricardo F.
Cortes, Sofia
Cristiano, Maria L.
author_role author
author2 Costa, Inês C. C.
Paixão, José A.
Mendes, Ricardo F.
Cortes, Sofia
Cristiano, Maria L.
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv Sapientia
dc.contributor.author.fl_str_mv Amado, Patrícia S. M.
Costa, Inês C. C.
Paixão, José A.
Mendes, Ricardo F.
Cortes, Sofia
Cristiano, Maria L.
dc.subject.por.fl_str_mv Antileishmanial chemotherapy
1,2,4-trioxanes
1,2,4,5-tetraoxanes
Pyrazoles
Endoperoxide– pyrazole hybrids
Prototropic tautomerism
topic Antileishmanial chemotherapy
1,2,4-trioxanes
1,2,4,5-tetraoxanes
Pyrazoles
Endoperoxide– pyrazole hybrids
Prototropic tautomerism
description Leishmaniases are among the most impacting neglected tropical diseases. In attempts to repurpose antimalarial drugs or candidates, it was found that selected 1,2,4-trioxanes, 1,2,4,5-tetraoxanes, and pyrazole-containing chemotypes demonstrated activity against <i>Leishmania</i> parasites. This study reports the synthesis and structure of trioxolane–pyrazole (<b>OZ1</b>, <b>OZ2</b>) and tetraoxane–pyrazole (<b>T1</b>, <b>T2</b>) hybrids obtained from the reaction of 3(5)-aminopyrazole with endoperoxide-containing building blocks. Interestingly, only the endocyclic amine of 3(5)-aminopyrazole was found to act as nucleophile for amide coupling. However, the fate of the reaction was influenced by prototropic tautomerism of the pyrazole heterocycle, yielding 3- and 5-aminopyrazole containing hybrids which were characterized by different techniques, including X-ray crystallography. The compounds were evaluated for <i>in vitro</i> antileishmanial activity against promastigotes of <i>L. tropica</i> and <i>L. infantum</i>, and for cytotoxicity against THP-1 cells. Selected compounds were also evaluated against intramacrophage amastigote forms of <i>L. infantum.</i> Trioxolane–pyrazole hybrids <b>OZ1</b> and <b>OZ2</b> exhibited some activity against <i>Leishmania</i> promastigotes, while tetraoxane–pyrazole hybrids proved inactive, most likely due to solubility issues. Eight salt forms, specifically tosylate, mesylate, and hydrochloride salts, were then prepared to improve the solubility of the corresponding peroxide hybrids and were uniformly tested. Biological evaluations in promastigotes showed that the compound <b>OZ1</b><b>•HCl</b> was the most active against both strains of <i>Leishmania</i>. Such finding was corroborated by the results obtained in assessments of the <i>L. infantum</i> amastigote susceptibility. It is noteworthy that the salt forms of the endoperoxide–pyrazole hybrids displayed a broader spectrum of action, showing activity in both strains of <i>Leishmania</i>. Our preliminary biological findings encourage further optimization of peroxide–pyrazole hybrids to identify a promising antileishmanial lead.
publishDate 2022
dc.date.none.fl_str_mv 2022-09-09T10:06:12Z
2022-08-24
2022-09-08T13:24:05Z
2022-08-24T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.1/18238
url http://hdl.handle.net/10400.1/18238
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Molecules 27 (17): 5401 (2022)
1420-3049
10.3390/molecules27175401
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133325619625984